The neuroscience of drug reward and addiction

ND Volkow, M Michaelides, R Baler - Physiological reviews, 2019 - journals.physiology.org
Drug consumption is driven by a drug's pharmacological effects, which are experienced as
rewarding, and is influenced by genetic, developmental, and psychosocial factors that …

Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?

SB Schagen, AS Tsvetkov, A Compter… - Nature Reviews …, 2022 - nature.com
One in three people will be diagnosed with cancer during their lifetime. The community of
cancer patients is growing, and several common cancers are becoming increasingly …

[HTML][HTML] Potential novel role of COVID-19 in Alzheimer's disease and preventative mitigation strategies

SX Naughton, U Raval… - Journal of Alzheimer's …, 2020 - content.iospress.com
There are a number of potential implications for the field of Alzheimer's disease (AD)
stemming from the global spread of SARS-CoV-2. Neuroinflammation is known to be a …

Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction

RE Wittenberg, SL Wolfman, M De Biasi, JA Dani - Neuropharmacology, 2020 - Elsevier
Nicotine is a highly addictive drug found in tobacco that drives its continued use despite the
harmful consequences. The initiation of nicotine abuse involves the mesolimbic dopamine …

[HTML][HTML] Nicotinic acetylcholine receptors in neurological and psychiatric diseases

AV Terry Jr, K Jones, D Bertrand - Pharmacological Research, 2023 - Elsevier
Neuronal nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels that are
widely distributed both pre-and post-synaptically in the mammalian brain. By modulating …

[HTML][HTML] Gray and white matter morphology in substance use disorders: a neuroimaging systematic review and meta-analysis

V Pando-Naude, S Toxto, S Fernandez-Lozano… - Translational …, 2021 - nature.com
Substance use disorders (SUDs) are characterized by a compulsion to seek and consume
one or more substances of abuse, with a perceived loss of control and a negative emotional …

[HTML][HTML] Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative …

AM Chaney, FR Lopez-Picon, S Serrière, R Wang… - Theranostics, 2021 - ncbi.nlm.nih.gov
Mouse models of Alzheimer's disease (AD) are valuable but do not fully recapitulate human
AD pathology, such as spontaneous Tau fibril accumulation and neuronal loss …

Anatoxin-a: Overview on a harmful cyanobacterial neurotoxin from the environmental scale to the molecular target

S Colas, B Marie, E Lance, C Quiblier… - Environmental …, 2021 - Elsevier
Abstract Anatoxin-a (ATX-a) is a neurotoxic alkaloid, produced by several freshwater
planktonic and benthic cyanobacteria (CB). Such CB have posed human and animal health …

[HTML][HTML] Nicotine: From discovery to biological effects

L Sansone, F Milani, R Fabrizi, M Belli… - International Journal of …, 2023 - mdpi.com
Nicotine, the primary psychoactive agent in tobacco leaves, has led to the widespread use of
tobacco, with over one billion smokers globally. This article provides a historical overview of …

Therapy for Alzheimer's disease: Missing targets and functional markers?

M Stoiljkovic, TL Horvath, M Hajós - Ageing research reviews, 2021 - Elsevier
The development of the next generation therapy for Alzheimer's disease (AD) presents a
huge challenge given the number of promising treatment candidates that failed in trials …